Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Happy Mohamed

6953 posts
Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Management
  • News

Neurobo Pharmaceuticals Appoints Hyung Heon Kim As Chief Executive Officer And President; Mr. Kim Succeeds Joseph Hooker, Who Served As Interim Chief Executive Officer And President Since January 2023

By Happy Mohamed
August 14, 8:48 AM
NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO), a clinical-stage biotechnology company on a quest to transform cardiometabolic diseases, today announced the appointment of current Board member, Hyung

NRBO

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • News

Ra Medical Systems Announces Allowance Of New Closure Device Patent; First Patent Out Of Six Applications On File For LockeT Product

By Happy Mohamed
August 14, 8:47 AM
First patent out of six applications on file for LockeT product FORT MILL, SC / ACCESSWIRE / August 14, 2023 / Ra Medical Systems, Inc. (NYSE:RMED) today announced that it has received notification of

RMED

Read More
2 minute read
  • Contracts
  • News

Foresight Signs Agreement With Global Vehicle Manufacturer

By Happy Mohamed
August 14, 8:42 AM
he agreement consists of two POC projects to evaluate Foresight's automatic camera calibration and stereo vision enhancement solutions   Ness Ziona, Israel, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Foresight

FRSX

Read More
3 minute read
  • News
  • Offerings

Longeveron Announces Pricing For Rights Offering And Expected Calendar; Rights Offering Priced At A $3.00 Subscription Price Per Share

By Happy Mohamed
August 14, 8:41 AM
Longeveron Inc. (NASDAQ:LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as

LGVN

Read More
2 minute read
  • Contracts
  • News

Booz Allen Awarded Thunderdome Production Agreement; Booz Allen Will Implement And Operate Thunderdome’s Zero Trust Network Access And Application Security Architecture; No Financial Terms Disclosed

By Happy Mohamed
August 14, 8:39 AM
Booz Allen Will Implement and Operate Thunderdome's Zero Trust Network Access and Application Security Architecture Booz Allen Hamilton (NYSE:BAH) today announced it was awarded a follow-on production other

BAH

Read More
1 minute read
  • News

Bowen Acquisition Corp Announces Separate Trading Of Its Ordinary Shares And Rights

By Happy Mohamed
August 14, 8:38 AM
Bowen Acquisition Corp (NASDAQ:BOWNU) (the "Company") announced today that, commencing on or about August 17, 2023, holders of its units sold in the Company's initial public offering may elect to separately

BOWNU

Read More
3 minute read
  • News

iCAD And Google Health Expand Integration of Google’s AI Technology With iCAD’s ProFound Breast Health Suite For 2D Mammography For Use As Independent Reader

By Happy Mohamed
August 14, 8:36 AM
iCAD, Inc. (NASDAQ:ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced it signed an amendment to its development and commercialization agreement

GOOG

Read More
3 minute read
  • Earnings
  • News

GGI Bio Reports Q2 2023 Financial Results And Provides Corporate Update; As Of June 30, 2023, The Company Had Cash And Cash Equivalents Of ~$4.8M

By Happy Mohamed
August 14, 8:35 AM
Rapidly advancing clinical pipeline across multiple high-value inflammatory, fibrotic and autoimmune diseases   On track to launch a Phase 2a biomarker study evaluating GRI-0621

GRI

Read More
1 minute read
  • Earnings
  • News

Applied UV Announces Selected Preliminary Q2 2023 Financial Results; Sees Q2 Revenue ~$10.8M Vs $10.9M Est; Reiterated Its Previous Guidance Of ~$45M In Revenue For 2023 Vs $43.3M Est

By Happy Mohamed
August 14, 8:34 AM
Total revenues for the second quarter of 2023 of approximately $10.8 million, representing an 83.6% increase over the comparable period in 2022   Gross profit grew to

AUVI

Read More
2 minute read
  • Earnings
  • News

Seelos Therapeutics Provides Q2 2023 Clinical Update

By Happy Mohamed
August 14, 8:24 AM
- Seelos expects to release top-line data in its registration directed study of SLS-002 (Intranasal Racemic Ketamine) for Acute Suicidal Ideation and Behavior (ASIB) in adults with Major Depressive Disorder (MDD) in

SEEL

Posts pagination

Previous 1 … 110 111 112 … 696 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service